Mirae Asset Global Etfs Holdings Ltd. Revolution Medicines, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 102,127 shares of RVMD stock, worth $4.22 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
102,127
Previous 90,043
13.42%
Holding current value
$4.22 Million
Previous $4.08 Million
9.51%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RVMD
# of Institutions
299Shares Held
179MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$707 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$554 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$548 Million3.09% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$447 Million0.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$392 Million0.22% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.63B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...